At BIOHM®, we developed the first clinically backed, data-powered microbiome ingredient BIOHM FX; enabled by our world-class database that combines bacterial and fungal sequencing with metadata. Today we’re partnering with the industry to develop new products and ingredients based on our data while accelerating the science of the microbiome through our bioinformatics and clinical trial services.
From our turnkey ingredients and formulations to cohort selection and postbiotic development, we are accelerating product innovation.
Whether you’re looking for an out-of-the-box test or a customized bioinformatics pipeline, we are meeting our client’s microbiome testing goals.
Having processed over tens of thousands of microbiome tests, BIOHM® is the preferred partner for clinical trial set-up and execution. Our scientific team designs and implements clinical trials for companies and institutions globally.
Showing breakdown of digestive biofilms through the use of BIOHM FX™. Before BIOHM FX™ left & after BIOHM FX™ right.
*In a recently conducted randomized, placebo-controlled study in 60 healthy adults over 6 weeks, BIOHM FX significantly improved self-reported ratings of gut function, mild bloating and abdominal discomfort compared to placebo (P<0.05). BIOHM FX also improved other measures of gut function within the treatment group after 6 weeks.
Cohorts from BIOHM’s microbiome database, analyzed to identify differences between the bacteria and fungi in the cohort (Blue), versus people with a healthy microbiome (Red).
We believe everyone should have access to science. At BIOHM® we are building technologies to make that a reality. From powering direct-to-consumer testing, to product development for industry leaders, we use our unique microbiome expertise and data to create products that can change people’s lives.
We are working with global industry leaders to create next generation products and ingredients based on our powerful and proprietary database that combines bacterial and fungal sequencing with over 50 metadata points.
BIOHM’s proprietary ‘plug and play’ software portal can provide customized reporting and science-based health solutions from any 16S, ITS and/or metagenomics raw sequencing dataset.
Our scientific team is supporting numerous clinical trials in both design, implementation and testing support. Our expertise in bacteria and fungi provides a robust platform to build scientific understanding that informs new product development.
Transmission electron microscopy image showing a cross-section of the fungus Candida Tropicalis (large cell in the middle) surrounded by multiple bacteria. These organisms cooperate together to cause gastrointestinal issues in Crohn’s disease patients.
THE MICROBIOME
INNOVATION COMPANY
